Hearing loss may be an under-recognized complication of diabetes, according to U.S. researchers, who found hearing loss to be roughly twice as common in people who have the disease as those who do not.
Read More »Diabetes In Control
Beta Cell Defect Linked To Type 2 Diabetes
Scientists at the Joslin Diabetes Center in Boston have found that a defect in the beta cells that make and release insulin has implications for the failure of these cells and the development of type 2 diabetes.
Read More »Sun May Prevent Type 1 Diabetes
Lack of exposure to the sun could play a role in development of type 1 diabetes and that vitamin D supplementation in early childhood may offer protection against the development of type 1 diabetes.
Read More »Dietary Antioxidants and Glucose Metabolism
Food with high antioxidant concentrations seems to have a protective effect, improving oxidative stress-mediated detrimental effects on the vicious circle among obesity, and insulin.
Read More »Diabetes Medication May Promote Eye Health
The diabetes medication rosiglitazone has been associated with a reduction in the likelihood of developing the eye disease called proliferative diabetic retinopathy. A study published in the June issue of Archives of Ophthalmology also found that diabetes patients using the drug were less likely to have reductions in visual acuity …
Read More »Carb-Loading at Breakfast Makes Dieting Easier Long-Term
Loading up on protein and carbohydrates at breakfast may help obese patients with metabolic syndrome stick to a low-calorie, low-carbohydrate diet the rest of the day, researchers found.
Read More »Home Blood Pressure Monitoring Plus Web-Based Pharmacy Care Improves Blood Pressure Control
Patients with hypertension who monitored their blood pressure from home and received Web-based pharmacist care showed greater improvement in blood pressure control than patients who received usual care, according to a study.
Read More »ADA: Investigational DPP-4 Inhibitor Effective as Add-On and Stand-Alone
Alogliptin, an investigational once-daily oral drug for type 2 diabetes, showed good efficacy and safety both as monotherapy and together with standard agents, researchers in five phase III trials stated at ADA Scientific Sessions.
Read More »ADA: Diabetes Prevention Hopes Revived for Thiazolidinedione
Pioglitazone (Actos) may prevent or delay progression to diabetes for patients with pre-diabetes by 81%, researchers found.
Read More »ADA: Exenatide Benefit Not Always Sustained in Type 2 Diabetes
Nearly half of patients taking exenatide (Byetta) for type 2 diabetes for more than a year in a small study discontinued it because of loss of efficacy, although many were combining it with insulin off-label. See Publisher’s Comments
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.